1. Catalog
  2. WCLC 2025 - Posters & ePosters
  3. P2.02.24 Zongertinib Has Activity Against NRG1 Fus ...
P2.02.24 Zongertinib Has Activity Against NRG1 Fusion Positive Tumor Cells
Back to course
Asset Subtitle
Yuji Shibata
Meta Tag
Speaker Yuji Shibata
Topic Tumor Biology – Preclinical Biology
Powered By